Washington Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.46M | Sell |
301,415
-5,769
| -2% | -$154K | 0.29% | 88 |
|
|
2025
Q4 | $7.65M | Sell |
307,184
-11,810
| -4% | -$298K | 0.25% | 89 |
|
|
2025
Q3 | $8.13M | Sell |
318,994
-137
| -0% | -$3.38K | 0.27% | 91 |
|
|
2025
Q2 | $7.74M | Buy |
319,131
+1,799
| +0.6% | +$42K | 0.27% | 89 |
|
|
2025
Q1 | $8.04M | Sell |
317,332
-5,145
| -2% | -$135K | 0.31% | 87 |
|
|
2024
Q4 | $8.56M | Sell |
322,477
-7,469
| -2% | -$203K | 0.31% | 84 |
|
|
2024
Q3 | $9.55M | Sell |
329,946
-4,465
| -1% | -$130K | 0.33% | 86 |
|
|
2024
Q2 | $9.36M | Sell |
334,411
-9,232
| -3% | -$254K | 0.34% | 86 |
|
|
2024
Q1 | $9.54M | Sell |
343,643
-2,996
| -0.9% | -$83.1K | 0.35% | 85 |
|
|
2023
Q4 | $9.98M | Sell |
346,639
-3,100
| -0.9% | -$93.7K | 0.39% | 79 |
|
|
2023
Q3 | $11.6M | Buy |
349,739
+2,404
| +0.7% | +$85K | 0.51% | 75 |
|
|
2023
Q2 | $12.7M | Buy |
347,335
+7,198
| +2% | +$280K | 0.54% | 71 |
|
|
2023
Q1 | $13.9M | Sell |
340,137
-169
| -0% | -$7.3K | 0.63% | 56 |
|
|
2022
Q4 | $17.4M | Sell |
340,306
-10,441
| -3% | -$501K | 0.81% | 37 |
|
|
2022
Q3 | $15.3M | Sell |
350,747
-2,619
| -0.7% | -$127K | 0.77% | 40 |
|
|
2022
Q2 | $18.5M | Buy |
353,366
+3,647
| +1% | +$186K | 0.87% | 31 |
|
|
2022
Q1 | $18.1M | Sell |
349,719
-2,598
| -0.7% | -$135K | 0.72% | 43 |
|
|
2021
Q4 | $20.8M | Sell |
352,317
-42,388
| -11% | -$2.1M | 0.78% | 36 |
|
|
2021
Q3 | $17M | Buy |
394,705
+6,894
| +2% | +$305K | 0.48% | 73 |
|
|
2021
Q2 | $15.2M | Buy |
387,811
+11,201
| +3% | +$436K | 0.43% | 78 |
|
|
2021
Q1 | $13.6M | Buy |
376,610
+13,557
| +4% | +$481K | 0.42% | 78 |
|
|
2020
Q4 | $13.4M | Sell |
363,053
-11,269
| -3% | -$413K | 0.43% | 76 |
|
|
2020
Q3 | $13M | Buy |
374,322
+16,540
| +5% | +$580K | 0.48% | 70 |
|
|
2020
Q2 | $11.1M | Sell |
357,782
-26,279
| -7% | -$893K | 0.46% | 74 |
|
|
2020
Q1 | $11.9M | Buy |
384,061
+19,269
| +5% | +$657K | 0.57% | 59 |
|
|
2019
Q4 | $13.6M | Buy |
364,792
+35,371
| +11% | +$1.26M | 0.53% | 66 |
|
|
2019
Q3 | $12M | Buy |
329,421
+10,813
| +3% | +$393K | 0.64% | 53 |
|
|
2019
Q2 | $13.1M | Buy |
318,608
+5,973
| +2% | +$237K | 0.72% | 48 |
|
|
2019
Q1 | $12.1M | Sell |
312,635
-14,762
| -5% | -$591K | 0.68% | 49 |
|
|
2018
Q4 | $13.6M | Sell |
327,397
-12,823
| -4% | -$532K | 0.86% | 34 |
|
|
2018
Q3 | $14.2M | Sell |
340,220
-11,846
| -3% | -$456K | 0.76% | 44 |
|
|
2018
Q2 | $12.1M | Buy |
352,066
+36,372
| +12% | +$1.24M | 0.65% | 55 |
|
|
2018
Q1 | $10.6M | Sell |
315,694
-15,816
| -5% | -$544K | 0.62% | 59 |
|
|
2017
Q4 | $11.4M | Buy |
331,510
+25
| +0% | +$852 | 0.64% | 56 |
|
|
2017
Q3 | $11.2M | Sell |
331,485
-1,210
| -0.4% | -$38.9K | 0.67% | 53 |
|
|
2017
Q2 | $10.6M | Buy |
332,695
+5,419
| +2% | +$171K | 0.65% | 55 |
|
|
2017
Q1 | $10.6M | Sell |
327,276
-5,418
| -2% | -$171K | 0.67% | 53 |
|
|
2016
Q4 | $10.3M | Sell |
332,694
-2,651
| -0.8% | -$80.9K | 0.66% | 53 |
|
|
2016
Q3 | $10.8M | Buy |
335,345
+3,425
| +1% | +$115K | 0.71% | 54 |
|
|
2016
Q2 | $11.1M | Sell |
331,920
-6,870
| -2% | -$219K | 0.75% | 52 |
|
|
2016
Q1 | $9.53M | Buy |
338,790
+11,015
| +3% | +$315K | 0.64% | 55 |
|
|
2015
Q4 | $10M | Sell |
327,775
-20,496
| -6% | -$645K | 0.69% | 54 |
|
|
2015
Q3 | $10.4M | Sell |
348,271
-10,475
| -3% | -$336K | 0.75% | 47 |
|
|
2015
Q2 | $11.4M | Buy |
358,746
+991
| +0.3% | +$32.3K | 0.75% | 47 |
|
|
2015
Q1 | $11.8M | Buy |
357,755
+10,659
| +3% | +$339K | 0.78% | 45 |
|
|
2014
Q4 | $10.3M | Buy |
347,096
+14,218
| +4% | +$408K | 0.7% | 53 |
|
|
2014
Q3 | $9.34M | Buy |
332,878
+9,619
| +3% | +$270K | 0.68% | 57 |
|
|
2014
Q2 | $9.1M | Buy |
323,259
+15,237
| +5% | +$434K | 0.67% | 58 |
|
|
2014
Q1 | $9.39M | Buy |
308,022
+179,980
| +141% | +$5.37M | 0.71% | 53 |
|
|
2013
Q4 | $3.72M | Buy |
128,042
+2,183
| +2% | +$63.5K | 0.28% | 85 |
|
|
2013
Q3 | $3.43M | Sell |
125,859
-666
| -0.5% | -$18.1K | 0.27% | 87 |
|
|
2013
Q2 | $3.36M | Buy |
+126,525
| New | +$3.5M | 0.28% | 86 |
|
Other funds holding PFE
VCM
VPM
Washington Trust's PFE Position: Q1 2026 in Review
Washington Trust reduced its Pfizer (PFE) stake by 1.9% in Q1 2026, selling an estimated $154K and leaving 301,415 shares worth $8.46M. The position accounts for 0.29% of the portfolio, ranked #88.
Washington Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.8M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Washington Trust held 301,415 shares of Pfizer worth $8.46M as of Q1 2026.
- Washington Trust sold 5,769 Pfizer shares in Q1 2026, an estimated $154K.
- Pfizer made up 0.29% of Washington Trust's portfolio in Q1 2026, its #88 holding.
- Washington Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Washington Trust's Pfizer position peaked at $20.8M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Washington Trust's 13F filing for Q1 2026, filed 6 Apr 2026.